JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Search

Cellectar Biosciences Inc

Closed

2.97 7.22

Overview

Share price change

24h

Current

Min

2.9699999999999998

Max

3.06

Key metrics

By Trading Economics

Employees

11

Market Stats

By TradingEconomics

Market Cap

15M

Previous open

-4.25

Previous close

2.97

Cellectar Biosciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 lut 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8 lut 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8 lut 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8 lut 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 lut 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8 lut 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8 lut 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8 lut 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8 lut 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7 lut 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 lut 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 lut 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 lut 2026, 02:46 UTC

Acquisitions, Mergers, Takeovers

Big Money, High Anxiety -- Barrons.com

6 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 lut 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 lut 2026, 21:40 UTC

Acquisitions, Mergers, Takeovers

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 lut 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 lut 2026, 21:17 UTC

Earnings

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 lut 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 lut 2026, 21:14 UTC

Acquisitions, Mergers, Takeovers

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 lut 2026, 21:13 UTC

Earnings

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 lut 2026, 21:13 UTC

Earnings

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 lut 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 lut 2026, 20:34 UTC

Earnings

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Peer Comparison

Price change

Cellectar Biosciences Inc Forecast

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Financials

$

help-icon Live chat